4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001493152-25-025161
10% owner sold 463,774 shares at an average $6.27 ($2,906,278)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SVF Endurance (Cayman) Ltd · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-24 | Sale : show line 1 in the form 10b5-1 | −227,803 | $6.15 | $1,400,783 | 14,346,180 | I |
| 2025-11-25 | Sale : show line 2 in the form 10b5-1 | −235,971 | $6.38 | $1,505,495 | 14,110,209 | I |
| Open-market sales · 463,774 sh · avg $6.27 · $2,906,278 | ||||||
Loading xslF345X05/ownership.xml…